Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RBMX2P3** is a **pseudogene** related to the RNA binding motif protein, X-linked 2 (RBMX2), and is not known to encode a functional protein product. Pseudogenes like RBMX2P3 are typically the result of gene duplication or retrotransposition and generally lack coding potential, although some pseudogene transcripts can have regulatory functions through interactions with microRNAs or RNA-binding proteins. There is no evidence that RBMX2P3 is a direct therapeutic target or has a defined biological or disease role. In general, some pseudogenes are implicated as modulators in gene expression networks in cancer and other diseases, but there are no disease associations or functional annotations for RBMX2P3 specifically. **Important context:** - The parent gene **RBMX2** is a protein-coding gene involved in pre-mRNA splicing in the minor spliceosome and nucleotide binding, but RBMX2P3 is not the protein-coding gene and has no similar functional annotation. - No evidence suggests RBMX2P3 is directly involved in drug interaction, patient biomarker selection, or as a therapeutic target. RBMX2P3 should be classified as a **non-coding pseudogene**, and **not as a therapeutic target**. If this target was intended to refer to an active gene or receptor, it may be a misidentification or erroneous entry, as "pseudogene" annotation means it does not function as a protein and is not a canonical drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein, X-linked 2 pseudogene 3 (RBMX2P3).